Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010. Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre.
Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements. It provide a diverse range of pharmaceutical products catering to various ther ...apeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
The Company started business through 4 regional headquarters in Gujarat in 2011. It launched a portfolio of nearly 25 products targeting essential therapeutic divisions in 2013. It expanded the operations to over 50 products, catering to both acute and chronic segments in 2015. This resulted the increase in portfolio to 70 products in 2019 and to over 100 in 2022. The Company enhanced the production to over 175 products in 2024. It established 3 operational divisions: Acute, Chronic, and OTC in 2024.
Company is planning the Initial Public Issue of 20,00,000 equity shares of face value of Rs 10 each through fresh issue.
Yes, you can invest in Aptus Pharma Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aptus Pharma Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aptus Pharma Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Aptus Pharma Ltd pay dividends? ›
Aptus Pharma Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Aptus Pharma Ltd ? ›
As of
04-11-2025 the share price for Aptus Pharma Ltd. is 132 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Aptus Pharma Ltd ? ›
The 52-week high and low of Aptus Pharma Ltd share price is ₹ 80.8 - ₹ 145.2 as of
04-11-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
